Filing Details
- Accession Number:
- 0001455244-10-000026
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2010-01-12 12:00:00
- Reporting Period:
- 2010-01-07
- Filing Date:
- 2010-01-12
- Accepted Time:
- 2010-01-12 15:32:37
- Original Submission Date:
- 2010-01-11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1278129 | Osteologix Inc. | OLGX OB | Pharmaceutical Preparations (2834) | 320104570 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1360542 | K/S Biotech Nordic | Ostergade 5, 3Rd Floor, Dk-1100 Copenhagen K G7 | No | No | Yes | No | |
| 1432652 | K/S Fund Opportunity Biotech Nordic | Ostergade 5, 3Rd Floor, Dk-1100 Copenhagen K G7 | No | No | Yes | No | |
| 1432680 | Aps Partner General Biotech Nordic | Ostergade 5, 3Rd Floor, Dk-1100 Copenhagen K G7 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2010-01-07 | 1,992,428 | $0.50 | 5,022,732 | No | 4 | P | Indirect | By Nordic Biotech Opportunity Fund K/S |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Nordic Biotech Opportunity Fund K/S |
Footnotes
- The price was misstated on the Reporting Person's original Form 4 filed January 11, 2010 and has been corrected in this amendment.
- Nordic Biotech General Partner ApS is the managing partner of Nordic Biotech Opportunity Fund K/S. Nordic Biotech General Partner ApS hereby disclaims any beneficial ownership of the securities held directly by Nordic Biotech Opportunity Fund K/S for purposes of Section 16 of the Act, except to the extent of its indirect pecuniary interest therein.
Billionaire Hedge Funds
